全文获取类型
收费全文 | 185701篇 |
免费 | 11685篇 |
国内免费 | 923篇 |
专业分类
耳鼻咽喉 | 1758篇 |
儿科学 | 4628篇 |
妇产科学 | 3350篇 |
基础医学 | 26810篇 |
口腔科学 | 4129篇 |
临床医学 | 17321篇 |
内科学 | 39034篇 |
皮肤病学 | 3622篇 |
神经病学 | 18129篇 |
特种医学 | 7523篇 |
外国民族医学 | 6篇 |
外科学 | 27389篇 |
综合类 | 2044篇 |
现状与发展 | 2篇 |
一般理论 | 153篇 |
预防医学 | 12658篇 |
眼科学 | 3908篇 |
药学 | 13024篇 |
2篇 | |
中国医学 | 283篇 |
肿瘤学 | 12536篇 |
出版年
2023年 | 933篇 |
2022年 | 1402篇 |
2021年 | 3172篇 |
2020年 | 2237篇 |
2019年 | 3266篇 |
2018年 | 3963篇 |
2017年 | 3071篇 |
2016年 | 3593篇 |
2015年 | 4132篇 |
2014年 | 5796篇 |
2013年 | 7946篇 |
2012年 | 12141篇 |
2011年 | 12883篇 |
2010年 | 7489篇 |
2009年 | 7128篇 |
2008年 | 12012篇 |
2007年 | 12769篇 |
2006年 | 12148篇 |
2005年 | 12494篇 |
2004年 | 11759篇 |
2003年 | 11206篇 |
2002年 | 10702篇 |
2001年 | 1815篇 |
2000年 | 1373篇 |
1999年 | 1960篇 |
1998年 | 2607篇 |
1997年 | 2042篇 |
1996年 | 1775篇 |
1995年 | 1619篇 |
1994年 | 1412篇 |
1993年 | 1372篇 |
1992年 | 978篇 |
1991年 | 986篇 |
1990年 | 781篇 |
1989年 | 741篇 |
1988年 | 722篇 |
1987年 | 702篇 |
1986年 | 630篇 |
1985年 | 701篇 |
1984年 | 808篇 |
1983年 | 736篇 |
1982年 | 959篇 |
1981年 | 860篇 |
1980年 | 742篇 |
1979年 | 469篇 |
1978年 | 512篇 |
1977年 | 526篇 |
1976年 | 466篇 |
1975年 | 390篇 |
1974年 | 342篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
91.
Peter Turrone Gary Remington Shitij Kapur José N Nobrega 《Neuropsychopharmacology》2003,28(8):1433-1439
Accumulating evidence suggests that antipsychotics (APs) that lead to sustained blockade of dopamine D(2) receptors are more likely to induce acute extrapyramidal side effects (EPS) compared to APs that only occupy D(2) receptors transiently. It is unclear, however, whether a similar relationship exists for long-term AP-induced motoric side effects like tardive dyskinesia (TD). The objective of this study was to ascertain whether transient (via daily subcutaneous (s.c.) injections) vs continuous (via osmotic minipump) AP-induced D(2) receptor occupancy differentially affects the development of haloperidol-induced vacuous chewing movements (VCMs), an animal model of TD. Six groups of 12 rats received 0.1, 0.25, or 1 mg/kg of haloperidol or vehicle (n=36) via osmotic minipump (to provide within-day sustained) or daily s.c. injection (within-day transient) for 8 weeks. VCMs were measured on a weekly basis and D(2) occupancy levels were measured in vivo using [(3)H]-raclopride at the end of the experiment. Minipump-treated rats developed HAL dose-dependent D(2) occupancies of 0.1 mg/kg/day (57%), 0.25 mg/kg/day (70%), and 1 mg/kg/day (88%). S.C.-treated rats also developed HAL dose-dependent D(2) occupancies of 0.1 mg/kg/day (83% peak, 3% trough), 0.25 mg/kg/day (89% peak, 0% trough), and 1 mg/kg/day (94% peak, 17% trough). A total of 43% of rats given 0.25 and 1 mg/kg/day of HAL via minipump developed high VCMs compared to only 8% of the rats given the same doses via daily s.c. injections. The 0.1 mg/kg dose did not give rise to VCMs beyond vehicle levels regardless of the route of administration. These findings support the contention that D(2) occupancy levels induced by chronic HAL must be high and sustained through the day before significant risk of VCMs, and perhaps also TD, emerges. 相似文献
92.
93.
94.
95.
Minoo Lenarz Martin Durisin Hartmut Becker Almuth Brandis Thomas Lenarz 《Skull base》2007,17(2):153-156
We report a case of synchronous olfactory bulb meningioma and undifferentiated carcinoma of the nose and paranasal sinuses that involved and destroyed the anterior skull base and mimicked intracranial invasion by a carcinoma. The heterogeneity of tissue types in the skull base gives rise to a diverse variety of benign and malignant neoplasms which have totally different prognoses. Synchronous development of benign and malignant primary tumors both originating from and involving the skull base at the same location is very rare and may cause confusion for both the skull base surgeon and neuroradiologist. 相似文献
96.
97.
98.
Tsuen‐Chiuan Tsai Peter H Harasym Sylvain Coderre Kevin McLaughlin Tyrone Donnon 《Medical education》2009,43(12):1188-1197
Context The assessment of ethical problem solving in medicine has been controversial and challenging. The purposes of this study were: (i) to create a new instrument to measure doctors’ decisions on and reasoning approach towards resolving ethical problems; (ii) to evaluate the scores generated by the new instrument for their reliability and validity, and (iii) to compare doctors’ ethical reasoning abilities between countries and among medical students, residents and experts. Methods This study used 15 clinical vignettes and the think‐aloud method to identify the processes and components involved in ethical problem solving. Subjects included volunteer ethics experts, postgraduate Year 2 residents and pre‐clerkship medical students. The interview data were coded using the instruments of the decision score and Ethical Reasoning Inventory (ERI). The ERI assessed the quality of ethical reasoning for a particular case (Part I) and for an individual globally across all the vignettes (Part II). Results There were 17 Canadian and 32 Taiwanese subjects. Based on the Canadian standard, the decision scores between Taiwanese and Canadian subjects differed significantly, but made no discrimination among the three levels of expertise. Scores on the ERI Parts I and II, which reflect doctors’ reasoning quality, differed between countries and among different levels of expertise in Taiwan, providing evidence of construct validity. In addition, experts had a greater organised knowledge structure and considered more relevant variables in the process of arriving at ethical decisions than did residents or students. The reliability of ERI scores was 0.70–0.99 on Part I and 0.75–0.80 on Part II. Conclusions Expertise in solving ethical problems could not be differentiated by the decisions made, but could be differentiated according to the reasoning used to make those decisions. The difference between Taiwanese and Canadian experts suggests that cultural considerations come into play in the decisions that are made in the course of providing humane care to patients. 相似文献
99.
OBJECTIVE: Based on recent safety and efficacy data, combined with the known pharmacokinetic parameters of aminoglycosides in the newborn, once-daily gentamicin should be preferable to the many other dosing regimens currently in use. Although there are growing data to support its use in term newborns, experience with preterm infants is more limited. In our Neonatal Intensive Care Unit, we experienced difficulties regarding complicated dosing regimens, actual dosing errors, and the tendency to check trough and peak levels around the third dose for infants receiving only a 48 hour course. Therefore, we conducted a quality improvement initiative in which we developed and tested a clinical practice guideline for the use of once-daily gentamicin for preterm and term infants that we hoped would yield trough and peak levels in our target range. METHODS: We combined a review of the published English language literature with pharmacokinetic analysis of our own data prior to initiation of this new regimen to design the following dosing regimen: <35 weeks gestation: 3 mg/kg q 24 hours, > or =35 weeks gestation: 4 mg/kg q 24 hours. Our goal serum levels were a trough < or =2 microg/ml and a peak between 6 and 12 microg/ml. We collected and analyzed trough and peak levels from all infants receiving this dosing regimen in the first week of life for at least 72 hours between 3/1/99 and 12/31/00. RESULTS: In total, 214 babies met our inclusion criteria, 75 of whom were <35 weeks gestation. 100% of babies of all gestational ages had a nontoxic trough level. For infants <35 weeks gestation, 79% had a therapeutic peak level, with a mean value of 6.8 microg/ml. For infants of at least 35 weeks gestation, 93% had a therapeutic peak level, with a mean value of 8.4 microg/ml. 92% of nontherapeutic peaks were too low. CONCLUSION: This study of once-daily gentamicin represents the largest sample size of pre-term infants published to date. The proposed regimen is simple and yields a high proportion of desirable levels. We recommend it for use in preterm and term newborns. 相似文献
100.